Basit öğe kaydını göster

Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis

dc.contributor.authorAktan, Melih
dc.contributor.authorBreuleux, Madlaina
dc.contributor.authorEnggaard, Lisbeth
dc.contributor.authorDEMİRKAN, FATİH
dc.contributor.authorARSLAN, ÖNDER
dc.contributor.authorTurgut, Mehmet
dc.contributor.authorFort, Stan
dc.contributor.authorForconi, Francesco
dc.contributor.authorMasud, Abdullah
dc.contributor.authorChyla, Brenda
dc.contributor.authorKater, Arnon
dc.contributor.authorPanagiotis, Panayiotidis
dc.contributor.authorThornton, Patrick
dc.contributor.authorTempescul, Adrian
dc.contributor.authorSkarbnik, Alan
dc.contributor.authorRossi, Davide
dc.contributor.authorMontillo, Marco
dc.contributor.authorLeber, Brian
dc.contributor.authorKarlsson, Karin
dc.contributor.authorHerishanu, Yair
dc.contributor.authorGonzalez Diaz, Marcos
dc.contributor.authorFerhanoglu, Burhan
dc.date.accessioned2021-03-05T07:19:56Z
dc.date.available2021-03-05T07:19:56Z
dc.identifier.citationKater A., Panagiotis P., Aktan M., ARSLAN Ö., DEMİRKAN F., Enggaard L., Ferhanoglu B., Gonzalez Diaz M., Herishanu Y., Karlsson K., et al., "Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis", LEUKEMIA & LYMPHOMA, cilt.61, ss.113-115, 2020
dc.identifier.issn1042-8194
dc.identifier.othervv_1032021
dc.identifier.otherav_933f7dc9-20f0-4bc0-9104-c32bb362c464
dc.identifier.urihttp://hdl.handle.net/20.500.12627/99258
dc.language.isoeng
dc.subjectHEMATOLOJİ
dc.subjectHematoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectOnkoloji
dc.titleMinimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis
dc.typeMakale
dc.relation.journalLEUKEMIA & LYMPHOMA
dc.contributor.departmentAbbVie , ,
dc.identifier.volume61
dc.identifier.startpage113
dc.identifier.endpage115
dc.contributor.firstauthorID2279232


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster